Finerenone in patients with chronic kidney disease and type 2 diabetes, with and without a history of heart failure: a secondary analysis of the FIDELIO-DKD trial
29 June 2021 (17:20 - 17:40)
Organised by:
Slides
About the speaker
National & Kapodistrian University of Athens Medical School, Athens (Greece)
2 More presentations in this session
Professor S. Solomon (Boston, US)
Access the full session
The Event
Heart Failure 2021
29 June 2021
17:20 CET
You may be interested in
Congress Session
Congress Session
